Free Trial

Novavax (NVAX) Insider Trading & Ownership

Novavax logo
$8.70 +0.02 (+0.23%)
(As of 12/20/2024 05:51 PM ET)

Novavax (NASDAQ:NVAX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$866,211.80
Get NVAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Novavax stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NVAX Insider Buying and Selling by Quarter

Novavax Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2024James F YoungDirectorSell7,500$14.09$105,675.00  
6/18/2024James F YoungDirectorSell7,500$13.72$102,900.00  
5/14/2024Filip DubovskyInsiderSell47,312$13.90$657,636.80  
(Data available from 1/1/2013 forward)

NVAX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Novavax includes Filip Dubovsky, Gregory M Glenn, James F Young, and John A Herrmann III. Learn more on insiders at NVAX.

1.00% of Novavax stock is owned by insiders. Learn more on NVAX's insider holdings.

The following insider purchased NVAX shares in the last 24 months: Gregory M Glenn ($28,940.00).

Insiders have purchased a total of 4,000 NVAX shares in the last 24 months for a total of $28,940.00 bought.

The following insiders have sold NVAX shares in the last 24 months: Filip Dubovsky ($657,636.80), and James F Young ($208,575.00).

Insiders have sold a total of 62,312 Novavax shares in the last 24 months for a total of $866,211.80 sold.

Novavax Key Executives

  • Mr. John Charles Jacobs M.B.A. (Age 57)
    President, CEO & Director
    Compensation: $1.33M
  • Mr. John Joseph Trizzino B.S. (Age 64)
    M.B.A., President & COO
    Compensation: $670.55k
  • Mr. James Patrick Kelly C.F.A. (Age 58)
    Executive VP, CFO & Treasurer
    Compensation: $716.17k
  • Mr. Mark Casey (Age 61)
    Executive VP, Chief Legal Officer & Corporate Secretary
    Compensation: $137.36k
  • Mr. Richard P. Crowley (Age 67)
    Executive VP & COO
  • Dr. Robert Walker M.D.
    Senior VP, Chief Medical Officer and Interim Head of R&D
  • Mr. Troy Morgan Esq. (Age 53)
    J.D., Senior VP, Deputy General Counsel & Chief Compliance Officer
  • Ms. Erika S. Trahan
    Associate Director of Investor & Public Relations
  • Mr. Ian J. Watkins (Age 61)
    Executive VP & Chief Human Resources Officer
  • Ms. Silvia Taylor M.B.A.
    Executive VP and Chief Corporate Affairs & Advocacy Officer


This page (NASDAQ:NVAX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners